Suppr超能文献

[肾细胞癌患者尿液中白细胞介素-1β、白细胞介素-6和肿瘤坏死因子-α水平的研究]

[Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma].

作者信息

Shi B, Nakazawa H, Ryoji O, Goya N, Ito F, Koga S, Okuda H, Kobayashi H, Toma H

机构信息

Department of Urology, Tokyo Women's Medical College.

出版信息

Hinyokika Kiyo. 1998 Mar;44(3):143-7.

PMID:9589873
Abstract

We examined the preoperative and postoperative, urinary levels of the cytokines, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in 14 patients with renal cell carcinoma (RCC), and 9 patients who underwent nephrectomy as donors (controls). Although urinary IL-1 beta was measurable in every subject, both IL-6 and TNF-alpha were undetectable in 12 of the 14 patients. None of the urinary cytokines showed levels significantly different from the controls preoperatively. Urinary levels of IL-1 beta showed no correlation with clinical stage or histological grade. Only urinary IL-1 beta was significantly elevated after nephrectomy, when compared with the controls (P < 0.05). However, urinary IL-1 beta showed no correlation with operative blood loss or postoperative infection. These findings suggest that measurement of urinary cytokines is not useful for diagnosis or monitoring of therapy in RCC patients.

摘要

我们检测了14例肾细胞癌(RCC)患者及9例接受肾切除术的供体患者(对照组)术前及术后尿液中细胞因子白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)的水平。虽然在每个受试者中均可检测到尿液IL-1β,但14例患者中有12例的IL-6和TNF-α均未检测到。术前,所有尿液细胞因子水平与对照组相比均无显著差异。尿液IL-1β水平与临床分期或组织学分级无关。与对照组相比,仅肾切除术后尿液IL-1β水平显著升高(P < 0.05)。然而,尿液IL-1β水平与手术失血量或术后感染无关。这些发现表明,检测尿液细胞因子对RCC患者的诊断或治疗监测并无帮助。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验